CN108186900B - A kind of Artemisia annua compound preparation for burn and scald and preparation method thereof - Google Patents
A kind of Artemisia annua compound preparation for burn and scald and preparation method thereof Download PDFInfo
- Publication number
- CN108186900B CN108186900B CN201810189215.0A CN201810189215A CN108186900B CN 108186900 B CN108186900 B CN 108186900B CN 201810189215 A CN201810189215 A CN 201810189215A CN 108186900 B CN108186900 B CN 108186900B
- Authority
- CN
- China
- Prior art keywords
- artemisia annua
- parts
- burn
- powder
- compound preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000001405 Artemisia annua Nutrition 0.000 title claims abstract description 45
- 240000000011 Artemisia annua Species 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 39
- 206010053615 Thermal burn Diseases 0.000 title claims abstract description 32
- 150000001875 compounds Chemical class 0.000 title claims abstract description 25
- 210000004369 blood Anatomy 0.000 claims abstract description 57
- 239000008280 blood Substances 0.000 claims abstract description 57
- 239000000944 linseed oil Substances 0.000 claims abstract description 24
- 235000021388 linseed oil Nutrition 0.000 claims abstract description 24
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 23
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 23
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 22
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 20
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 20
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 19
- 239000004863 Frankincense Substances 0.000 claims abstract description 19
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 17
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229940116229 borneol Drugs 0.000 claims abstract description 17
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 17
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 17
- 241001233914 Chelidonium majus Species 0.000 claims abstract description 16
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 16
- 235000005865 Symphytum officinale Nutrition 0.000 claims abstract description 12
- 235000013871 bee wax Nutrition 0.000 claims abstract description 12
- 239000012166 beeswax Substances 0.000 claims abstract description 12
- 241001313857 Bletilla striata Species 0.000 claims abstract description 9
- 240000002299 Symphytum officinale Species 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 244000299790 Rheum rhabarbarum Species 0.000 claims abstract 4
- 239000000843 powder Substances 0.000 claims description 28
- 239000003921 oil Substances 0.000 claims description 18
- 235000019198 oils Nutrition 0.000 claims description 18
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 16
- 238000005303 weighing Methods 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 11
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims description 10
- 235000003097 Artemisia absinthium Nutrition 0.000 claims description 10
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims description 10
- 239000001138 artemisia absinthium Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 238000001816 cooling Methods 0.000 claims description 8
- 240000007594 Oryza sativa Species 0.000 claims description 6
- 235000007164 Oryza sativa Nutrition 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 235000009566 rice Nutrition 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 239000003610 charcoal Substances 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 3
- 238000002481 ethanol extraction Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 240000006891 Artemisia vulgaris Species 0.000 claims 3
- 241000606680 Coxiella <Bacteria> Species 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 abstract description 11
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 7
- 230000000202 analgesic effect Effects 0.000 abstract description 5
- 230000002421 anti-septic effect Effects 0.000 abstract description 4
- 231100000241 scar Toxicity 0.000 abstract description 4
- 206010063560 Excessive granulation tissue Diseases 0.000 abstract description 3
- 210000001126 granulation tissue Anatomy 0.000 abstract description 3
- 230000012010 growth Effects 0.000 abstract description 2
- 206010020718 hyperplasia Diseases 0.000 abstract description 2
- 239000003814 drug Substances 0.000 description 48
- 208000002193 Pain Diseases 0.000 description 23
- 230000036407 pain Effects 0.000 description 22
- 229940079593 drug Drugs 0.000 description 21
- 230000000694 effects Effects 0.000 description 18
- 241000219061 Rheum Species 0.000 description 13
- 230000008961 swelling Effects 0.000 description 13
- 241000581682 Sanguisorba Species 0.000 description 12
- 208000027418 Wounds and injury Diseases 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 11
- 208000014674 injury Diseases 0.000 description 11
- 210000003491 skin Anatomy 0.000 description 11
- 239000002398 materia medica Substances 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 9
- 208000032843 Hemorrhage Diseases 0.000 description 9
- 230000000740 bleeding effect Effects 0.000 description 9
- 239000000306 component Substances 0.000 description 9
- 239000002674 ointment Substances 0.000 description 9
- 239000002253 acid Substances 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 8
- 230000000144 pharmacologic effect Effects 0.000 description 8
- 239000000341 volatile oil Substances 0.000 description 8
- 240000001851 Artemisia dracunculus Species 0.000 description 7
- 206010052428 Wound Diseases 0.000 description 7
- 239000011347 resin Substances 0.000 description 7
- 229920005989 resin Polymers 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 235000003826 Artemisia Nutrition 0.000 description 6
- 208000000616 Hemoptysis Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 244000030166 artemisia Species 0.000 description 6
- 235000009052 artemisia Nutrition 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 241001071917 Lithospermum Species 0.000 description 5
- 206010039509 Scab Diseases 0.000 description 5
- 241001442052 Symphytum Species 0.000 description 5
- UNNKKUDWEASWDN-UHFFFAOYSA-N alkannin Natural products CC(=CCC(O)c1cc(O)c2C(=O)C=CC(=O)c2c1O)C UNNKKUDWEASWDN-UHFFFAOYSA-N 0.000 description 5
- -1 chelidonine 41% Natural products 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 235000004426 flaxseed Nutrition 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 231100000252 nontoxic Toxicity 0.000 description 5
- 230000003000 nontoxic effect Effects 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 4
- VOMDIEGPEURZJO-UHFFFAOYSA-N Deoxyshikonin Chemical compound C1=CC(O)=C2C(=O)C(CCC=C(C)C)=CC(=O)C2=C1O VOMDIEGPEURZJO-UHFFFAOYSA-N 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- GHKISGDRQRSCII-ZOCIIQOWSA-N chelidonine Chemical compound C1=C2[C@H]3N(C)CC4=C(OCO5)C5=CC=C4[C@H]3[C@@H](O)CC2=CC2=C1OCO2 GHKISGDRQRSCII-ZOCIIQOWSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 230000002475 laxative effect Effects 0.000 description 4
- 230000037257 muscle growth Effects 0.000 description 4
- 230000001151 other effect Effects 0.000 description 4
- 238000010926 purge Methods 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 201000008827 tuberculosis Diseases 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- MHVJRKBZMUDEEV-UHFFFAOYSA-N (-)-ent-pimara-8(14),15-dien-19-oic acid Natural products C1CCC(C(O)=O)(C)C2C1(C)C1CCC(C=C)(C)C=C1CC2 MHVJRKBZMUDEEV-UHFFFAOYSA-N 0.000 description 3
- NBGQZFQREPIKMG-UHFFFAOYSA-N 3beta-hydroxy-beta-boswellic acid Natural products C1CC(O)C(C)(C(O)=O)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C NBGQZFQREPIKMG-UHFFFAOYSA-N 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- NEZONWMXZKDMKF-JTQLQIEISA-N Alkannin Chemical compound C1=CC(O)=C2C(=O)C([C@@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-JTQLQIEISA-N 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- NBGQZFQREPIKMG-PONOSELZSA-N Boswellic acid Chemical compound C1C[C@@H](O)[C@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C NBGQZFQREPIKMG-PONOSELZSA-N 0.000 description 3
- 206010006802 Burns second degree Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 208000034507 Haematemesis Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 241000208202 Linaceae Species 0.000 description 3
- 235000004431 Linum usitatissimum Nutrition 0.000 description 3
- 241000249820 Lipotes vexillifer Species 0.000 description 3
- 241000475481 Nebula Species 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 208000007107 Stomach Ulcer Diseases 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000001784 detoxification Methods 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000003211 malignant effect Effects 0.000 description 3
- 230000009756 muscle regeneration Effects 0.000 description 3
- 230000037311 normal skin Effects 0.000 description 3
- YLYBTZIQSIBWLI-UHFFFAOYSA-N octyl acetate Chemical compound CCCCCCCCOC(C)=O YLYBTZIQSIBWLI-UHFFFAOYSA-N 0.000 description 3
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- MXYATHGRPJZBNA-UHFFFAOYSA-N 4-epi-isopimaric acid Natural products C1CCC(C(O)=O)(C)C2C1(C)C1CCC(C=C)(C)CC1=CC2 MXYATHGRPJZBNA-UHFFFAOYSA-N 0.000 description 2
- VWNVDXRJGNLURQ-UHFFFAOYSA-N 5-methoxy-2-phenylchromen-7-one Chemical compound C=1C=C2C(OC)=CC(=O)C=C2OC=1C1=CC=CC=C1 VWNVDXRJGNLURQ-UHFFFAOYSA-N 0.000 description 2
- UCZJPQIEFFTIEV-UHFFFAOYSA-N 5-methoxy-6-methyl-2-phenylchromen-7-one Chemical compound C=1C=C2C(OC)=C(C)C(=O)C=C2OC=1C1=CC=CC=C1 UCZJPQIEFFTIEV-UHFFFAOYSA-N 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241001435059 Artemisia argyi Species 0.000 description 2
- 235000010894 Artemisia argyi Nutrition 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241001480043 Arthrodermataceae Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 235000018062 Boswellia Nutrition 0.000 description 2
- 206010006458 Bronchitis chronic Diseases 0.000 description 2
- 206010007558 Cardiac failure chronic Diseases 0.000 description 2
- PBAYDYUZOSNJGU-UHFFFAOYSA-N Chelidonic acid Chemical compound OC(=O)C1=CC(=O)C=C(C(O)=O)O1 PBAYDYUZOSNJGU-UHFFFAOYSA-N 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 208000032544 Cicatrix Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000034656 Contusions Diseases 0.000 description 2
- QXKAIJAYHKCRRA-JJYYJPOSSA-N D-arabinonic acid Chemical group OC[C@@H](O)[C@@H](O)[C@H](O)C(O)=O QXKAIJAYHKCRRA-JJYYJPOSSA-N 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010017711 Gangrene Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010061245 Internal injury Diseases 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- 229930192627 Naphthoquinone Natural products 0.000 description 2
- 206010028851 Necrosis Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 240000007817 Olea europaea Species 0.000 description 2
- 201000005702 Pertussis Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 206010040849 Skin fissures Diseases 0.000 description 2
- 206010061577 Ulcer haemorrhage Diseases 0.000 description 2
- UTOUNDHZJFIVPK-QGZVFWFLSA-N [(1r)-1-(5,8-dihydroxy-1,4-dioxonaphthalen-2-yl)-4-methylpent-3-enyl] 3-methylbutanoate Chemical compound C1=CC(O)=C2C(=O)C([C@@H](CC=C(C)C)OC(=O)CC(C)C)=CC(=O)C2=C1O UTOUNDHZJFIVPK-QGZVFWFLSA-N 0.000 description 2
- WNFXUXZJJKTDOZ-HNNXBMFYSA-N [(1s)-1-(5,8-dihydroxy-1,4-dioxonaphthalen-2-yl)-4-methylpent-3-enyl] acetate Chemical compound C1=CC(O)=C2C(=O)C([C@@H](OC(C)=O)CC=C(C)C)=CC(=O)C2=C1O WNFXUXZJJKTDOZ-HNNXBMFYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000002924 anti-infective effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 201000009267 bronchiectasis Diseases 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- ZKOTWKIEVACBFM-QHCPKHFHSA-N ccg-35578 Chemical compound C1([C@H]2OC=3C=4C=5C=C(OC6=CC(=O)C=C(C=56)OC=4C=C(C=3CC2)OC)C=2C=CC=CC=2)=CC=CC=C1 ZKOTWKIEVACBFM-QHCPKHFHSA-N 0.000 description 2
- 208000003796 chancre Diseases 0.000 description 2
- GHKISGDRQRSCII-UHFFFAOYSA-N chelidonine Natural products C1=C2C3N(C)CC4=C(OCO5)C5=CC=C4C3C(O)CC2=CC2=C1OCO2 GHKISGDRQRSCII-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 208000007451 chronic bronchitis Diseases 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 231100000895 deafness Toxicity 0.000 description 2
- 230000037304 dermatophytes Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000000718 duodenal ulcer Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 125000004383 glucosinolate group Chemical group 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000016354 hearing loss disease Diseases 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- MXYATHGRPJZBNA-KRFUXDQASA-N isopimaric acid Chemical compound [C@H]1([C@](CCC2)(C)C(O)=O)[C@@]2(C)[C@H]2CC[C@@](C=C)(C)CC2=CC1 MXYATHGRPJZBNA-KRFUXDQASA-N 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 229930013686 lignan Natural products 0.000 description 2
- 150000005692 lignans Chemical class 0.000 description 2
- 235000009408 lignans Nutrition 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- 150000002791 naphthoquinones Chemical class 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 229910052573 porcelain Inorganic materials 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- DBLLWHYTKRSJEV-UHFFFAOYSA-N sanguisorbic acid dilactone Chemical compound OC(=O)C1=CC(O)=C(O)C(OC=2C=3C(=O)OC=4C(O)=C(O)C=C5C(=O)OC(C=3C5=4)=C(O)C=2O)=C1 DBLLWHYTKRSJEV-UHFFFAOYSA-N 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- WNFXUXZJJKTDOZ-UHFFFAOYSA-N shikonin acetate Natural products C1=CC(O)=C2C(=O)C(C(OC(C)=O)CC=C(C)C)=CC(=O)C2=C1O WNFXUXZJJKTDOZ-UHFFFAOYSA-N 0.000 description 2
- UTOUNDHZJFIVPK-UHFFFAOYSA-N shikonin isovalerate Natural products C1=CC(O)=C2C(=O)C(C(CC=C(C)C)OC(=O)CC(C)C)=CC(=O)C2=C1O UTOUNDHZJFIVPK-UHFFFAOYSA-N 0.000 description 2
- 208000006379 syphilis Diseases 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- SWGJCIMEBVHMTA-UHFFFAOYSA-K trisodium;6-oxido-4-sulfo-5-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-2-sulfonate Chemical compound [Na+].[Na+].[Na+].C1=CC=C2C(N=NC3=C4C(=CC(=CC4=CC=C3O)S([O-])(=O)=O)S([O-])(=O)=O)=CC=C(S([O-])(=O)=O)C2=C1 SWGJCIMEBVHMTA-UHFFFAOYSA-K 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- MHVJRKBZMUDEEV-APQLOABGSA-N (+)-Pimaric acid Chemical compound [C@H]1([C@](CCC2)(C)C(O)=O)[C@@]2(C)[C@H]2CC[C@](C=C)(C)C=C2CC1 MHVJRKBZMUDEEV-APQLOABGSA-N 0.000 description 1
- SOHAVULMGIITDH-ZXPSTKSJSA-N (1S,9R,14E)-14-(1H-imidazol-5-ylmethylidene)-2,11-dimethoxy-9-(2-methylbut-3-en-2-yl)-2,13,16-triazatetracyclo[7.7.0.01,13.03,8]hexadeca-3,5,7,10-tetraene-12,15-dione Chemical compound C([C@]1(C2=CC=CC=C2N([C@@]21NC1=O)OC)C(C)(C)C=C)=C(OC)C(=O)N2\C1=C\C1=CNC=N1 SOHAVULMGIITDH-ZXPSTKSJSA-N 0.000 description 1
- PZRKAAPKQGONFG-UHFFFAOYSA-N (2S)-3,4-dihydro-5-methoxy-6-methyl-2-phenyl-2H-1-benzopyran-7-ol Natural products C1CC=2C(OC)=C(C)C(O)=CC=2OC1C1=CC=CC=C1 PZRKAAPKQGONFG-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- QWUWMCYKGHVNAV-UHFFFAOYSA-N 1,2-dihydrostilbene Chemical group C=1C=CC=CC=1CCC1=CC=CC=C1 QWUWMCYKGHVNAV-UHFFFAOYSA-N 0.000 description 1
- VQECOUFHPVSSCD-UHFFFAOYSA-N 1-phenanthren-1-ylphenanthrene Chemical class C1=CC2=CC=CC=C2C2=C1C(C1=C3C=CC=4C(C3=CC=C1)=CC=CC=4)=CC=C2 VQECOUFHPVSSCD-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- PHZOWSSBXJXFOR-UHFFFAOYSA-N 2-Propenyl glucosinolate Natural products OCC1OC(SC(CC=C)=NOS(O)(=O)=O)C(O)C(O)C1O PHZOWSSBXJXFOR-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- BTXXTMOWISPQSJ-UHFFFAOYSA-N 4,4,4-trifluorobutan-2-one Chemical compound CC(=O)CC(F)(F)F BTXXTMOWISPQSJ-UHFFFAOYSA-N 0.000 description 1
- PZRKAAPKQGONFG-HNNXBMFYSA-N 7-Hydroxy-5-methoxy-6-methylflavan Chemical compound C1([C@H]2OC=3C=C(O)C(C)=C(C=3CC2)OC)=CC=CC=C1 PZRKAAPKQGONFG-HNNXBMFYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- BQACOLQNOUYJCE-FYZZASKESA-N Abietic acid Natural products CC(C)C1=CC2=CC[C@]3(C)[C@](C)(CCC[C@@]3(C)C(=O)O)[C@H]2CC1 BQACOLQNOUYJCE-FYZZASKESA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 208000012260 Accidental injury Diseases 0.000 description 1
- 241001133760 Acoelorraphe Species 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002153 Anal fissure Diseases 0.000 description 1
- 208000016583 Anus disease Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000208837 Asterales Species 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 238000011725 BALB/c mouse Methods 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- 208000003508 Botulism Diseases 0.000 description 1
- 244000140786 Brassica hirta Species 0.000 description 1
- 235000011371 Brassica hirta Nutrition 0.000 description 1
- 206010051548 Burn infection Diseases 0.000 description 1
- 206010006797 Burns first degree Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 241001017738 Chelidonium <beetle> Species 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 240000006766 Cornus mas Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- QUUCYKKMFLJLFS-UHFFFAOYSA-N Dehydroabietan Natural products CC1(C)CCCC2(C)C3=CC=C(C(C)C)C=C3CCC21 QUUCYKKMFLJLFS-UHFFFAOYSA-N 0.000 description 1
- NFWKVWVWBFBAOV-UHFFFAOYSA-N Dehydroabietic acid Natural products OC(=O)C1(C)CCCC2(C)C3=CC=C(C(C)C)C=C3CCC21 NFWKVWVWBFBAOV-UHFFFAOYSA-N 0.000 description 1
- 208000012239 Developmental disease Diseases 0.000 description 1
- DGMKKPXKWAAJMT-UHFFFAOYSA-N Dracooxepine Natural products C=1C=2OC(C=3C=CC=CC=3)CCC=2C(OC)=CC=1OC1(OC2=C(C(=C(C)C(O)=C2)OC)C=CO1)C1=CC=CC=C1 DGMKKPXKWAAJMT-UHFFFAOYSA-N 0.000 description 1
- DGMKKPXKWAAJMT-YCIOTGQKSA-N Dracooxepine Chemical compound C([C@H](OC=1C=2)C=3C=CC=CC=3)CC=1C(OC)=CC=2OC1(OC2=C(C(=C(C)C(O)=C2)OC)C=CO1)C1=CC=CC=C1 DGMKKPXKWAAJMT-YCIOTGQKSA-N 0.000 description 1
- FWKBXSPDFCAHFN-UHFFFAOYSA-N Dracorubin Natural products C1CC=2C(OC)=CC=3OC(C=45)=C(C)C(=O)C=C5OC(C=5C=CC=CC=5)=CC=4C=3C=2OC1C1=CC=CC=C1 FWKBXSPDFCAHFN-UHFFFAOYSA-N 0.000 description 1
- 241000571940 Dracula Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000009531 Fissure in Ano Diseases 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010017999 Gastrointestinal pain Diseases 0.000 description 1
- 206010061459 Gastrointestinal ulcer Diseases 0.000 description 1
- 241000208680 Hamamelis mollis Species 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- BVRYLTBIGIAADD-MRXNPFEDSA-N Isobutylshikonin Chemical compound C1=CC(O)=C2C(=O)C([C@@H](CC=C(C)C)OC(=O)C(C)C)=CC(=O)C2=C1O BVRYLTBIGIAADD-MRXNPFEDSA-N 0.000 description 1
- 206010023215 Joint effusion Diseases 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028034 Mouth ulceration Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 241001057584 Myrrha Species 0.000 description 1
- 208000006595 Necrotizing Ulcerative Gingivitis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010031256 Osteomyelitis chronic Diseases 0.000 description 1
- SOHAVULMGIITDH-UHFFFAOYSA-N Oxaline Natural products O=C1NC23N(OC)C4=CC=CC=C4C3(C(C)(C)C=C)C=C(OC)C(=O)N2C1=CC1=CN=CN1 SOHAVULMGIITDH-UHFFFAOYSA-N 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000218180 Papaveraceae Species 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000005228 Pericardial Effusion Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- YNPNZTXNASCQKK-UHFFFAOYSA-N Phenanthrene Natural products C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 206010037083 Prurigo Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 240000004980 Rheum officinale Species 0.000 description 1
- 235000008081 Rheum officinale Nutrition 0.000 description 1
- 235000008090 Rheum palmatum Nutrition 0.000 description 1
- 240000001745 Rheum palmatum Species 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 244000173853 Sanguisorba officinalis Species 0.000 description 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 201000010001 Silicosis Diseases 0.000 description 1
- PHZOWSSBXJXFOR-MYMDCHNCSA-N Sinigrin Natural products S(=O)(=O)(O/N=C(\S[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)/CC=C)O PHZOWSSBXJXFOR-MYMDCHNCSA-N 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 206010041235 Snoring Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000003028 Stuttering Diseases 0.000 description 1
- 206010042566 Superinfection Diseases 0.000 description 1
- 201000002014 Suppurative Otitis Media Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241001480050 Trichophyton violaceum Species 0.000 description 1
- DZGWFCGJZKJUFP-UHFFFAOYSA-N Tyramine Natural products NCCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-N 0.000 description 1
- 206010046274 Upper gastrointestinal haemorrhage Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000001454 anthracenes Chemical class 0.000 description 1
- 229930182482 anthraquinone glycoside Natural products 0.000 description 1
- 150000008139 anthraquinone glycosides Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000001775 anti-pathogenic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- BATBOVZTQBLKIL-QGZVFWFLSA-N beta,beta-Dimethylacrylshikonin Chemical compound C1=CC(O)=C2C(=O)C([C@H](OC(=O)C=C(C)C)CC=C(C)C)=CC(=O)C2=C1O BATBOVZTQBLKIL-QGZVFWFLSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229940097217 cardiac glycoside Drugs 0.000 description 1
- 239000002368 cardiac glycoside Substances 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000005465 channeling Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 201000009151 chronic rhinitis Diseases 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 229940039585 comfrey leaf extract Drugs 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- NFWKVWVWBFBAOV-MISYRCLQSA-N dehydroabietic acid Chemical compound OC(=O)[C@]1(C)CCC[C@]2(C)C3=CC=C(C(C)C)C=C3CC[C@H]21 NFWKVWVWBFBAOV-MISYRCLQSA-N 0.000 description 1
- 229940118781 dehydroabietic acid Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229930191187 dracoflavan Natural products 0.000 description 1
- FWKBXSPDFCAHFN-DEOSSOPVSA-N dracorubin Chemical compound C1([C@H]2OC=3C=4C=5C=C(OC6=CC(=O)C(C)=C(C=56)OC=4C=C(C=3CC2)OC)C=2C=CC=CC=2)=CC=CC=C1 FWKBXSPDFCAHFN-DEOSSOPVSA-N 0.000 description 1
- 244000186071 dragons blood palm Species 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 208000010515 dystocia Diseases 0.000 description 1
- 201000010582 ecthyma Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 230000008472 epithelial growth Effects 0.000 description 1
- 238000006735 epoxidation reaction Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 208000030304 gastrointestinal bleeding Diseases 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- BVRYLTBIGIAADD-UHFFFAOYSA-N isobutyryl shikonin Natural products C1=CC(O)=C2C(=O)C(C(CC=C(C)C)OC(=O)C(C)C)=CC(=O)C2=C1O BVRYLTBIGIAADD-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 239000013521 mastic Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 210000001819 pancreatic juice Anatomy 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 150000002987 phenanthrenes Chemical class 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- QKFAFSGJTMHRRY-OCFLFPRFSA-M potassium;[(e)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanylbut-3-enylideneamino] sulfate Chemical compound [K+].OC[C@H]1O[C@@H](S\C(CC=C)=N\OS([O-])(=O)=O)[C@H](O)[C@@H](O)[C@@H]1O QKFAFSGJTMHRRY-OCFLFPRFSA-M 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 229910052957 realgar Inorganic materials 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- MHVJRKBZMUDEEV-KRFUXDQASA-N sandaracopimaric acid Chemical compound [C@H]1([C@](CCC2)(C)C(O)=O)[C@@]2(C)[C@H]2CC[C@@](C=C)(C)C=C2CC1 MHVJRKBZMUDEEV-KRFUXDQASA-N 0.000 description 1
- YZVSLDRKXBZOMY-KNOXWWKRSA-N sandaracopimaric acid Natural products CC(=C)[C@]1(C)CCC[C@]2(C)[C@H]3CC[C@](C)(C=C)C=C3CC[C@@H]12 YZVSLDRKXBZOMY-KNOXWWKRSA-N 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 235000017291 sinigrin Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 description 1
- 229960002256 spironolactone Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 150000008143 steroidal glycosides Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 229960003732 tyramine Drugs 0.000 description 1
- DZGWFCGJZKJUFP-UHFFFAOYSA-O tyraminium Chemical compound [NH3+]CCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-O 0.000 description 1
- 201000008587 ulcerative stomatitis Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 238000011514 vinification Methods 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 229940118846 witch hazel Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Insects & Arthropods (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于烧烫伤的米蒿复方制剂及其制备方法,以重量份数计,包含以下原料:米蒿种子,地榆,血竭,大黄,乳香,没药,白屈菜,紫草,白芨,蜂蜡,冰片以及亚麻籽油,本发明对于烧烫伤有明显的止痛消炎、收敛、防腐、促进新生肉芽组织生长以及减少烧烫伤后疤痕增生的功效。The invention discloses a compound preparation of Artemisia annua for burns and scalds and a preparation method thereof. In parts by weight, the compound preparation comprises the following raw materials: Artemisia annua seeds, Burnet, dried blood, rhubarb, frankincense, myrrh, celandine , Comfrey, Bletilla striata, beeswax, borneol and linseed oil, the present invention has obvious analgesic and anti-inflammatory, astringent, antiseptic, promoting the growth of new granulation tissue and reducing scar hyperplasia after burns and scalds.
Description
技术领域technical field
本发明涉及一种用于烧烫伤的米蒿复方制剂及其制备方法,属于中药技术领域。The invention relates to a compound preparation of Artemisia annua for burns and scalds and a preparation method thereof, belonging to the technical field of traditional Chinese medicines.
背景技术Background technique
根据现有资料,我国烧伤年发生率约2%,总死亡率约1.35/10万。烧烫伤致伤原因日趋复杂,除了常见的火、沸水等烫伤外,近年来出现了被火锅、摩托车排气管烫伤,多为Ⅱ、Ⅲ度伤,不易痊愈,而且发病率有上升趋势。在0~6岁儿童意外伤害情况调查结果表明:排在第二位的是烧烫伤,烧烫伤比例为13.83%,是儿童致伤致残的主要原因,造成儿童身心发育障碍,还给家庭和社会带来沉重的经济负担【李家伟,景琳,熊颖,潘宇佳,荆媛,赖倩,余伟.农村0~6岁儿童健康管理服务利用现状与儿童健康问题调查分析.中国全科医学,2014,17(30):3590-3593.】。青少年和老年人的烧烫伤一般为生活烧伤,以轻、中度为主。据估计我国约有5%的烧烫伤者需住院治疗,95%轻伤者可在家庭和门诊治疗。住院烧伤病人约有10%发生不同程度的残疾,我国每年因烧烫伤新发生约10万残疾人。According to the available data, the annual incidence of burns in my country is about 2%, and the total mortality rate is about 1.35/100,000. The causes of burns and scalds are becoming more and more complicated. In addition to common burns such as fire and boiling water, burns from hot pot and motorcycle exhaust pipes have occurred in recent years. Most of them are second- and third-degree injuries, which are not easy to heal, and the incidence rate is on the rise. The survey results of accidental injuries among children aged 0-6 show that burns and scalds ranked second, with a proportion of 13.83%, which is the main cause of injury and disability in children, causing physical and mental developmental disorders in children, and returning to the family and the family. The society brings a heavy economic burden [Li Jiawei, Jing Lin, Xiong Ying, Pan Yujia, Jing Yuan, Lai Qian, Yu Wei. Investigation and Analysis of the Utilization Status of Children's Health Management Services and Children's Health Problems in Rural 0-6 Years Old. Chinese General Medicine, 2014, 17(30): 3590-3593.]. The burns of young people and the elderly are generally life burns, mainly mild to moderate. It is estimated that about 5% of burns in my country require hospitalization, and 95% of minor injuries can be treated at home and outpatient clinics. About 10% of hospitalized burn patients suffer from different degrees of disability, and about 100,000 people with disabilities are newly diagnosed with burns and scalds in my country every year.
烧伤创面是烧伤感染、脏器损害等并发症的源头,如何有效地促进创面愈合,一直是烧伤治疗中研究的热点。西医治疗烧烫伤的药物主要是抗生素,长期使用不仅会使细菌产生耐药性并诱发二重感染,还会降低人体的免疫力。中药一直是祖国医学领域的一块瑰宝,中药及其制剂在治疗烧烫伤方面使用广泛、发展迅速、剂型丰富,有着西药无法比拟的优势;烧伤中药在抗感染、促进创面愈合方面也展现了其独特疗效。中药常用于治疗烧伤的中药剂型有:油剂、膏剂、散剂、膜剂、水溶剂、喷雾剂、还有霜剂、成膜剂等【王晓妮,乔彬,周德斌,张建春.中药烧伤膏的研究现状及应用前景.甘肃科技,2016,5(32):124-126.】。中药烧伤膏剂由于其方便、有效的优势一直在中药烧伤药中占有较高的比重。Burn wound is the source of complications such as burn infection and organ damage. How to effectively promote wound healing has always been a hot research topic in burn treatment. The drugs used in western medicine to treat burns and scalds are mainly antibiotics. Long-term use will not only cause bacteria to develop drug resistance and induce superinfection, but also reduce the body's immunity. Traditional Chinese medicine has always been a treasure in the field of medicine in the motherland. Traditional Chinese medicine and its preparations are widely used in the treatment of burns and scald, with rapid development and rich dosage forms, which have incomparable advantages over Western medicine; traditional Chinese medicine for burns also shows its uniqueness in anti-infection and promoting wound healing. curative effect. The traditional Chinese medicine formulations commonly used in the treatment of burns are: oil, ointment, powder, film, water solvent, spray, cream, film-forming agent, etc. [Wang Xiaoni, Qiao Bin, Zhou Debin, Zhang Jianchun. Research on Traditional Chinese Medicine Burn Ointment Status and application prospects. Gansu Science and Technology, 2016, 5(32): 124-126.]. Traditional Chinese medicine burn ointment has always occupied a high proportion in traditional Chinese medicine burn medicine due to its convenient and effective advantages.
经药理和临床试验证明中药软膏剂有很好的疗效,是烧伤外治最常用的制剂之一。外用膏剂中的软膏与膏药在中国应用甚早,在《黄帝内经》(素问)“痈疽篇”中已有“疏砭之,涂以豕膏”的记载。中药烧伤膏主要适用于I度和Ⅱ度烧伤,膏剂富有黏性,外敷患处,既可避免外来刺激和细菌感染,又可消炎止痛,改善局部血液循环,有利于创面组织的修复和再生,适用于各种烧伤创面。Pharmacological and clinical trials have proved that traditional Chinese medicine ointment has good curative effect and is one of the most commonly used preparations for external treatment of burns. The ointment and plaster in the external ointment have been used in China for a long time. In the "Carbuncle Chapter" of the "Huangdi Neijing" (Su Wen), there is a record of "sparse the Bianstone and apply the pig ointment". Traditional Chinese medicine burn ointment is mainly suitable for first-degree and second-degree burns. The ointment is viscous and can be applied externally to the affected area, which can not only avoid external irritation and bacterial infection, but also reduce inflammation and pain, improve local blood circulation, and is conducive to the repair and regeneration of wound tissue. in various burn wounds.
发明内容SUMMARY OF THE INVENTION
本发明所要解决的技术问题是,提供一种对于烧烫伤有明显的止痛消炎、收敛、防腐、促进新生肉芽组织生长以及减少烧烫伤后疤痕增生功效的米蒿复方制剂。The technical problem to be solved by the present invention is to provide an Artemisia annua compound preparation that has obvious effects of relieving pain, reducing inflammation, astringent, antiseptic, promoting the growth of new granulation tissue and reducing the hyperplasia of scars after burns and scalds.
为解决上述技术问题,本发明采用的技术方案为:In order to solve the above-mentioned technical problems, the technical scheme adopted in the present invention is:
一种用于烧烫伤的米蒿复方制剂,以重量份数计,包含以下原料:米蒿种子,地榆,血竭,大黄,乳香,没药,白屈菜,紫草,白芨,蜂蜡,冰片以及亚麻籽油。A compound preparation of Artemisia annua for burns and scalds, in parts by weight, comprising the following raw materials: Artemisia annua seeds, Burnet, dried blood, rhubarb, frankincense, myrrh, celandine, comfrey, Bletilla striata, beeswax, Borneol and flaxseed oil.
以重量份数计,包含以下原料:米蒿种子20-30份,地榆4-6份,血竭2-3份,大黄4-6份,乳香0.8-1.2份,没药0.8-1.2份,白屈菜8-12份,紫草20-30份,白芨4-6份,蜂蜡4-6份,冰片2-3份以及亚麻籽油70-110份。In parts by weight, it contains the following raw materials: 20-30 parts of Artemisia annua seeds, 4-6 parts of Burnet, 2-3 parts of dried blood, 4-6 parts of rhubarb, 0.8-1.2 parts of frankincense, 0.8-1.2 parts of myrrh , Celandine 8-12 parts, Lithospermum 20-30 parts, Bletilla striata 4-6 parts, Beeswax 4-6 parts, Borneol 2-3 parts and Flaxseed oil 70-110 parts.
其中,米蒿(Artemisia dalai-lamae)是菊目Asterales、菊科Asteraceae、蒿属Artemisia植物。别名:达赖蒿、驴驴蒿(甘肃、内蒙古),碱蒿(甘肃),“达赖-沙里尔日”(蒙语名)。昧辛、苦,性大寒,具有泻肺定喘,祛痰止咳,行水消肿的功效,能够祛痰定喘、强心利尿、通肠润便。米蒿种子含硫苷(芥子苷,sinigrin)、脂肪油,榨成的油叫米蒿油,对慢性支气管有一定治疗功效;米蒿特有的辛辣味可以刺激身体的代谢机能,含有大量的粗纤维,通便效果明显。《本草纲目》:无毒。《藏药》象才那保:地上部分治炭疽《青藏药鉴》。种子治疫疽药,镇刺痛《中国藏药》。《蒙药》贡图格一布如,哈不毕勒,达瑞雅干:种子用于胆热,肺热,血热,肉毒,水肿,胸满喘咳,胸肋胀痛,肺源性心脏病。其药理作用表明:米蒿种子有强心、利尿、调节血脂、抑制炎性渗出、抗菌、抗癌的作用。临床用于治疗胸腔、腹腔、心包积液;治疗肺部白沫痰和痰多;治疗肺心病慢性心衰,也能治疗其他心脏病之慢性心衰;治疗关节腔积液。Among them, Artemisia dalai-lamae is a plant of the order Asterales, Asteraceae, and Artemisia of the genus Artemisia. Aliases: Artemisia Dalai Lama, Artemisia donkey (Gansu, Inner Mongolia), Artemisia annua (Gansu), "Dalai-Shahrir Day" (Mongolian name). It is pungent, bitter, and cold in nature. It has the effects of purging the lungs and calming asthma, removing phlegm and relieving cough, and removing phlegm and reducing swelling. The seeds of Artemisia annua contain glucosinolates (glucosinolates, sinigrin) and fatty oil. The oil extracted is called Artemisia annua oil, which has a certain therapeutic effect on chronic bronchial tubes. Fiber, laxative effect is obvious. "Compendium of Materia Medica": non-toxic. "Tibetan Medicine" Xiangcai Nabao: the above-ground part of the treatment of anthrax "Qinghai-Tibet Medicine". Seeds cure gangrene, relieve stinging pain "Chinese Tibetan Medicine". "Mongolian Medicine" Gongtuge Yiburu, Habubil, Dariya Gan: Seeds are used for gallbladder heat, lung heat, blood heat, botulism, edema, chest fullness, asthma and cough, chest and ribs pain, pulmonary origin heart disease. Its pharmacological effects show that: Artemisia annua seeds have cardiotonic, diuretic, regulating blood lipid, inhibiting inflammatory exudation, antibacterial and anticancer effects. It is clinically used for the treatment of pleural, abdominal and pericardial effusions; for the treatment of pulmonary foamy phlegm and excessive phlegm; for the treatment of pulmonary heart disease and chronic heart failure, as well as for the treatment of chronic heart failure of other heart diseases; for the treatment of joint effusion.
亚麻籽油是亚麻籽榨取的油类,亚麻籽(flaxseed或linseed)又称胡麻籽,是亚麻科、亚麻属的一年生或多年生草本植物亚麻的种子。亚麻籽油中α-亚麻酸含量为53%,有抗肿瘤,抗血栓,降血脂,营养脑细胞,调节植物神经等作用;亚麻籽油中还含有VE,是一种强有效的自由基清除剂,有延缓衰老和抗氧化的作用;还含有数量可观的高级脂肪醇,甾醇和羟类等。亚麻籽油有以下功效:(1)肌肤娇柔亮泽;(2)改善关节炎;(3)改善器官组织发炎;(4)促进细胞健康;(5)降低胆固醇等多种作用。其中α-亚麻酸和木酚素在烧烫伤中具有消炎、消除瘢痕的作用。因此在本中药制剂组方中亚麻籽油既作为基质使用,同时又具有较好的治疗作用。Flaxseed oil is the oil extracted from flaxseed, flaxseed (flaxseed or linseed), also known as flaxseed, is the seed of flax, an annual or perennial herb of the Flax family and the genus Flax. The content of alpha-linolenic acid in flaxseed oil is 53%, which has the functions of anti-tumor, anti-thrombosis, lowering blood lipids, nourishing brain cells, and regulating autonomic nerves; flaxseed oil also contains VE, which is a strong and effective free radical scavenger. It has anti-aging and antioxidant effects; it also contains a considerable amount of higher fatty alcohols, sterols and hydroxyls. Flaxseed oil has the following effects: (1) Delicate and bright skin; (2) Improve arthritis; (3) Improve organ tissue inflammation; (4) Promote cell health; (5) Reduce cholesterol and other effects. Among them, α-linolenic acid and lignans have anti-inflammatory and scar removal effects in burns. Therefore, the linseed oil is not only used as a matrix, but also has a better therapeutic effect in the traditional Chinese medicine formulation.
白屈菜(Chelidonium majus)为罂粟科白屈菜属下的一个种。出自《救荒本草》,全草入药。性凉,味苦;有小毒。具有镇病、止咳、利尿、解毒等功效。主治:镇病、止咳、利尿、解毒。主胃痛、腹痛、肠炎;痢疾、慢性支气管炎、百日咳、咳嗽、黄疸、水肿、腹水、疥癣疮肿、蛇虫咬伤。《中国药植志》:治胃肠疼痛及溃疡。外用为疥癣药及消肿药,以生汁涂布之。含有多种生物碱,其中有白屈菜碱41%、原阿片碱22%、人血草碱17%;还含白屈菜酸、苹果酸、柠檬酸、琥珀酸、胆碱、甲胺、组胺、酪胺、皂苷、黄酮醇、白屈菜醇,还含强心苷,多量维生素C。所含的白屈菜碱属原鸦片碱一类,对末梢的作用较强,而对中枢则较弱,能麻痹感觉及运动神经末梢,但对神经干无作用。特别适用于外用制剂中,起到消肿、镇痛的作用。Celandine (Chelidonium majus) is a species of the genus Chelidonium in the family Papaveraceae. From "Famine Rescue Materia Medica", the whole herb is used as medicine. Cool in nature, bitter in taste; slightly poisonous. Has analgesic, cough, diuretic, detoxification and other effects. Indications: sedative, cough, diuretic, detoxification. Main stomach pain, abdominal pain, enteritis; dysentery, chronic bronchitis, whooping cough, cough, jaundice, edema, ascites, scabies sores, snake bites. "Chinese Medicine Plants": treatment of gastrointestinal pain and ulcers. For external use, it is a scabies medicine and a detumescence medicine, and it is coated with raw juice. Contains a variety of alkaloids, including chelidonine 41%, proto-opioid 22%, human blood oxaline 17%; also contains chelidonic acid, malic acid, citric acid, succinic acid, choline, methylamine, Histamine, tyramine, saponins, flavonols, celandine alcohol, cardiac glycosides, and a lot of vitamin C. The chelidonine contained in it belongs to a class of proto-opioid, which has a strong effect on the peripheral, but weaker on the center, and can paralyze the sensory and motor nerve terminals, but has no effect on the nerve trunk. It is especially suitable for external preparations, and has the effect of reducing swelling and analgesia.
地榆(Sanguisorba officinalis L.)是蔷薇科地榆属多年生草本植物。地榆根入药,性寒,味苦酸,无毒;归肝、肺、肾和大肠经。有凉血止血,清热解毒,培清养阴,消肿敛疮等功效。根中含多种鞣质成分:地榆素(sanguiin),地偷酸双内酯(sanguisorbicaciddilactone)等;还含有2种没食子酰金缕梅糖衍生物:5,2’-双-O-没食子酰金缕梅糖(5,2’-di-O-galloylhamamelose),2’,3,5-三-O-没食子酰-D-呋喃金缕梅糖。现代医学研究证明:地榆具有止血凉血、清热解毒、收敛止泻及抑制多种致病微生物和肿瘤的作用,可治疗吐血、血痢、烧灼伤、湿疹、上消化道出血、溃疡病大出血、便血、崩漏、结核性脓疡及慢性骨髓炎等疾病。《纲目》中记载:地榆,除下焦热,治大小便血证。止血,取上截切片炒用,其梢则能行血,不可不知。杨士瀛云:诸疮痛者加地榆,痒者加黄芩。《本草选旨》中记载:地榆,以之止血,取上截炒用。以之行血、取下截生用。以之敛血,则同归、芍。以之清热,则同归、连。以之治湿,则同归、芩。以之治血中之痛,则同归、萸。以之温经而益血,则同归、姜。大抵酸敛寒收之剂,得补则守,得寒则凝,得温暖而益血归经,在善用者自得之而已。《本经》又疗金疮,《别录》谓止脓血,恶疮热疮,可作金疮膏,皆即此清火凉血之功用。《药物图考》:调敷汤火伤,疳疮溃烂。Burnet (Sanguisorba officinalis L.) is a perennial herb of the Rosaceae family. Burnet root is used as medicine, cold in nature, bitter and sour in taste, non-toxic; it belongs to the liver, lung, kidney and large intestine meridians. It has the functions of cooling blood to stop bleeding, clearing heat and detoxifying, cultivating clearing and nourishing yin, reducing swelling and astringing sores. The root contains a variety of tannin components: sanguiin, sanguisorbicaciddilactone, etc.; also contains 2 kinds of galloyl witch hazel sugar derivatives: 5,2'-bis-O-gallic 5,2'-di-O-galloylhamamelose, 2',3,5-tri-O-galloyl-D-furanoylhamamelose. Modern medical research has proved that Diul has the functions of hemostasis and cooling blood, clearing heat and detoxification, astringent and antidiarrheal, and inhibiting various pathogenic microorganisms and tumors. It can treat hematemesis, blood dysentery, burns, eczema, upper gastrointestinal bleeding, ulcer bleeding , blood in the stool, metrorrhagia, tuberculous abscess and chronic osteomyelitis and other diseases. "Compendium" records: Diyu, removes coke heat, and treats blood in stool and stool. To stop bleeding, take the upper section and fry it, the tip of it can bleed, you must know. Yang Shiying said: add Burnet for sores and pain, and Scutellaria for itching. It is recorded in the "Selected Purpose of Materia Medica": Burnet, to stop bleeding, take the upper cut for frying. Use it for blood, take it off and cut it off. To astringe blood, then the same Gui, peony. To clear the heat, then the same return, even. To treat dampness, then the same Gui, Qin. To treat the pain in the blood, then the same Gui, dogwood. To warm the meridians and benefit blood, then the same Gui, ginger. Most of the sour astringent and cold-retracting agent, if it is tonic, it should be guarded, if it is cold, it will coagulate, and if it is warm, it will benefit blood and return to the meridians. "Benjing" also treats golden sores, "Bielu" says to stop pus and blood, aversion to hot sores, it can be used as golden sore paste, which is the function of clearing fire and cooling blood. "Drug Map Examination": Applying decoction for burns, chancre sore canker.
大黄为蓼科植物掌叶大黄Rheum palmatum L.、唐古特大黄Rheum tanguticumMaxim.ex Balf.或药用大黄Rheum officinale Baill.的干燥根及根茎。味苦,性寒,无毒。具有泻下攻积,清热泻火,凉血解毒,活血祛瘀等功效。属泻下药,生用泻下作用较强,熟用则泻下作用较缓而长于泻火解毒,清利湿热;酒制功擅活血,且善清上焦血分之熟;炒炭常用于凉血止血。用于治疗肠道积滞,大便秘结,血热吐衄,目赤,咽痛,牙龈肿痛,热毒疮疡,水火烫伤,血瘀经闭,跌打损伤,湿热黄疸,热淋。《本草纲目》:治汤火伤。用大黄生研,调蜜涂搽,不惟止痛,而且灭瘢【http://zhongyaocai360.com/】。大黄含有蒽醌苷,还含有近40%的草酸钙,其他成分还有大黄素、胶质、树脂、大黄酸、大黄泻脂和具收敛性的大黄鞣酸。现代药理作用主要为:(1)对消化系统的影响:①泻下作用:通过刺激大肠粘膜,使肠蠕动增加而泻下;另外还可抑制肠细胞膜上Na+、K+—ATP酶,阻碍Na+转运,使肠内渗透压升高,保留大量水分,促进肠蠕动而泻下;②利胆、保肝;③促进胰液分泌、抑制胰酶活性;④抗胃及十二指肠溃疡。(2)对血液系统的影响:①止血作用;②降血脂。(3)抗感染作用:①抗病原微生物作用;②抗炎、解热作用;③免疫调节;④抗衰老抗氧化作用。Rhubarb is the dried root and rhizome of Rheum palmatum L., Rheum tanguticumMaxim.ex Balf. or Rheum officinale Baill. of the Polygonaceae plant. Bitter in taste, cold in nature, non-toxic. It has the functions of purging and attacking accumulation, clearing heat and purging fire, cooling blood and detoxifying, promoting blood circulation and removing blood stasis. It is a laxative. It has a strong laxative effect when used raw, and has a slower laxative effect when it is cooked. It is longer than purging fire and detoxifying, clearing dampness and heat; wine making is good at activating blood, and is good at clearing the blood of Shangjiao; stir-fried charcoal is often used for cooling Bleeding to stop bleeding. It is used for the treatment of intestinal stagnation, constipation, epistaxis due to blood heat, red eyes, sore throat, swollen gums, heat-toxic sores, water-fire scalds, blood stasis amenorrhea, traumatic injuries, damp-heat jaundice, and hot stranguria. "Compendium of Materia Medica": governance soup fire injury. Using rhubarb to study and apply honey, not only relieve pain, but also eliminate scars [http://zhongyaocai360.com/]. Rhubarb contains anthraquinone glycosides, and also contains nearly 40% calcium oxalate, and other components are emodin, gum, resin, rhein, rhubarb epoxidation, and astringent rhubarb tannin. The main modern pharmacological effects are: (1) Effects on the digestive system: (1) Diarrhea effect: by stimulating the mucosa of the large intestine, the peristalsis is increased and diarrhea; in addition, it can also inhibit the Na+, K+-ATPase on the intestinal cell membrane and hinder the transport of Na+ It increases the osmotic pressure in the intestine, retains a lot of water, and promotes peristalsis and diarrhea; ② promotes the gallbladder and protects the liver; ③ promotes the secretion of pancreatic juice and inhibits the activity of pancreatic enzymes; ④ resists gastric and duodenal ulcers. (2) Effects on the blood system: ① hemostasis; ② lowering blood lipids. (3) Anti-infection effects: ① anti-pathogenic microorganisms; ② anti-inflammatory and antipyretic effects; ③ immune regulation; ④ anti-aging and antioxidant effects.
紫草(Lithospermumerythrorhizon Sieb.et Zucc.)是紫草科紫草属多年生草本植物的干燥根。性味:苦,寒。功能主治:凉血,活血,清热,解毒。主治温热斑疹,湿热黄疸,紫癜,吐、衄、尿血,淋浊,热结便秘,烧伤,湿疹,丹毒,痈疡。《药性论》:“治恶疮、瘑癣。”主要化学成分:紫草根含萘醌衍生物、脂肪酸。萘醌衍生物有紫草素(紫草醌,Shikonin)、乙酰紫草素(Acetylshikonin)、去氧紫草素(Deoxyshikonin)、异丁基紫草素(Isobutyshi-konin)、异戊酰紫草素(Isovalerylshikonin)、β,β-二甲基丙烯酰紫草素(β,β-Dimethyla-crylshikonin)等;脂肪酸主要为软脂酸、油酸及亚油酸等。药理作用:(1)抗菌、抗炎作用:紫草对京科68-1病毒试管内有抑制作用,对金黄色葡萄球菌、灵杆菌亦能抑制。前苏联产紫草的酊剂对化脓菌、大肠杆菌有抑制作用;并能加速上皮生长以及治疗烧伤。(2)对循环系统的影响。(3)抗肿瘤作用。(4)避孕作用。(5)其他作用:新疆软紫草煎剂对兔有缓和的解热作用,对家兔离体子宫及小肠平滑肌有不恒定的兴奋作用,口服煎剂能加强小肠的紧张性与收缩,静脉注射则无此反应。紫草叶提取物可使兔血糖下降,增加豚鼠肠管张力等作用。Comfrey (Lithospermumerythrorhizon Sieb.et Zucc.) is the dried root of a perennial herb of the genus Lithospermaceae. Nature and taste: bitter, cold. Functions and indications: cooling blood, promoting blood circulation, clearing heat, detoxifying. Indications: Warm rash, damp-heat jaundice, purpura, vomiting, epistaxis, hematuria, stranguria, constipation due to heat, burns, eczema, erysipelas, carbuncle ulcers. "Medicinal Properties": "Treat malignant sores and tinea." Main chemical components: Comfrey root contains naphthoquinone derivatives and fatty acids. Naphthoquinone derivatives include shikonin (Shikonin, Shikonin), acetyl shikonin (Acetylshikonin), deoxyshikonin (Deoxyshikonin), isobutyl shikonin (Isobutyshi-konin), isovaleryl shikonin Isovalerylshikonin, β, β-dimethylacryloyl shikonin (β, β-Dimethyla-crylshikonin), etc.; fatty acids are mainly palmitic acid, oleic acid and linoleic acid. Pharmacological effects: (1) Antibacterial and anti-inflammatory effects: Comfrey has an inhibitory effect on Jingke 68-1 virus in vitro, and can also inhibit Staphylococcus aureus and Lingobacter. The tincture of comfrey from the former Soviet Union has inhibitory effects on pyogenic bacteria and Escherichia coli; it can accelerate epithelial growth and treat burns. (2) Influence on the circulatory system. (3) Anti-tumor effect. (4) Contraceptive effect. (5) Other effects: Xinjiang soft comfrey decoction has a mild antipyretic effect on rabbits, and has an unstable excitatory effect on the isolated uterus and small intestinal smooth muscle of rabbits. Oral decoction can strengthen the tension and contraction of the small intestine. Injections have no such reaction. Comfrey leaf extract can reduce blood sugar in rabbits and increase intestinal tension in guinea pigs.
血竭(Daemonorops draco Bl.)为棕榈科植物麒麟竭果实渗出的树脂经加工制成。具有活血定痛,化瘀止血,敛疮生肌。用于跌打损伤,心腹瘀痛,外伤出血,疮疡不敛。《本草备要》:补,和血,敛疮。甘咸。色赤入血分。补心包、肝血不足,专除血痛,散瘀生新,为和血之圣药。治内伤血聚,金疮折跌,疮口不合,止痛生肌。性急,不可多使,引脓(血竭单入血分、乳香、没药兼入气分,皆木脂也)。出南番。色赤,以染透指甲者为真(假者是海母血,味大咸,有腥气)。单碾用(同众药捣,则作尘飞)【http://zhongyaocai360.com/】。化学成分为:血竭红素(dracorubin),血竭素(dracorhodin),去甲基血竭红素(nordracorubin),去甲基血竭素(nordracorhodin),(2S)-5-甲氧基-6-甲基黄烷-7-醇,(2S)-5-甲氧基蓼烷-7-醇,2,4-二羟基-5-甲基-6-甲氧基耳酮,血竭黄烷(dracoflavan)A,血竭二氧杂庚醚(dracooxepine),另含海松酸(pimaric acid),异海松酸(isopimaric acid),松香酸(abietic acid),去氢松香酸(dehydroabieticacid),山达海松酸(sandaracopimaricacid)。药理作用为:抗真菌作用,止血作用。配没药,其活血破瘀之力增强,用于跌打损伤,瘀血肿痛。配乳香,活血生肌,又敛疮,伸筋,故可用于恶疮痈疽,久不收口,金疮出血,创口不合等症。Dried blood (Daemonorops draco Bl.) is processed from the resin exuded from the fruit of Draconis dactyloides, a palm plant. It has the functions of promoting blood circulation and relieving pain, removing blood stasis and stopping bleeding, astringing sores and promoting muscle growth. For bruises, confidant stasis pain, traumatic bleeding, sores and ulcers do not converge. "Compendium of Materia Medica": tonic, and blood, astringent sores. Sweet and salty. Red into the blood. Supplements the pericardium and liver blood deficiency, removes blood pain, disperses stasis and regenerates, and is the holy medicine for reconciling blood. Governs internal injury and blood gathering, gold sore collapse, sore incompatibility, pain relief and muscle regeneration. Impatient, do not use too much, and induce pus (blood dried blood alone enters the blood component, frankincense, myrrh also enter the qi component, all of which are lignans). Out of the South. The color is red, and it is true that the nails are dyed through (the false one is the blood of the sea mother, the taste is salty, and there is a fishy smell). It is used for single grinding (the same medicine is pounded, then it is used as dust fly) [http://zhongyaocai360.com/]. The chemical composition is: dracorubin, dracorhodin, nordracorubin, nordracorhodin, (2S)-5-methoxy- 6-Methylflavan-7-ol, (2S)-5-methoxypolygan-7-ol, 2,4-dihydroxy-5-methyl-6-methoxyurone, Dracula Alkane (dracoflavan) A, dracooxepine, pimaric acid, isopimaric acid, abietic acid, dehydroabietic acid, mountain Dapimaric acid (sandaracopimaricacid). Pharmacological effects are: antifungal effect, hemostatic effect. With myrrh, its power of promoting blood circulation and breaking blood stasis is enhanced, and it is used for bruises, blood stasis, swelling and pain. With frankincense, it promotes blood circulation and promotes muscle growth, and also astringes sores and stretches tendons, so it can be used for malignant sores and carbuncles, long-term non-removal of mouths, bleeding from golden sores, and incompatibility of wounds.
乳香(Boswellia carteri.)为橄榄科植物乳香树Boswellia carterii Birdw.及同属植物Boswellia bhaurdajiana Birdw.树皮渗出的树脂。性味辛、苦,温。具有活血行气止痛,消肿生肌的功效。主治胸痹心痛,胃脘疼痛,痛经经闭,产后瘀阻,症瘕腹痛,风湿痹痛,筋脉拘挛,跌打损伤,痈肿疮疡。《本草纲目》:消痈疽诸毒,托里护心,活血定痛,治妇人难产,折伤。乳香香窜,能入心经,活血定痛,故为痈疽疮疡、心腹痛要药。……产科诸方多用之,亦取其活血之功耳。《名医别录》:“疗风水毒肿,去恶气。”“疗风瘾疹痒毒。”化学成分为:树脂60%-70%,树胶27%-35%,挥发油3%-8%。树脂的主要成分为游离a,β-乳香脂酸(a,β-boswellic acid)33%,结合乳香脂酸13.5%;乳香树脂烃(olibanoresene)33%;树胶为阿拉伯杂多糖酸(arabic acid)的钙盐和镁盐20%,西黄芪胶粘素(bassorin)6%。此外,尚含苦味质0.5%和挥发油。药理作用主要为:(1)镇痛作用:用小鼠热板法证明乳香挥发油有镇痛作用,提取挥发油后的残渣无效。挥发油中的镇痛主要成为乙酸正辛酯。(2)消炎防腐作用:乳香能促进多核白血球增加,以吞噬死亡的血球及细胞,改善新陈代谢,从而起消炎作用。与没药、雄黄等合用,可消肿生肌,为臣药。Frankincense (Boswellia carteri.) is the resin exuded from the bark of the olive plant Boswellia carterii Birdw. and Boswellia bhaurdajiana Birdw. Pungent, bitter, warm in nature. It has the effect of promoting blood circulation, relieving pain, reducing swelling and promoting muscle growth. Indications: chest pain and heartache, epigastric pain, dysmenorrhea, amenorrhea, postpartum stasis, abdominal pain due to Zhengjia, rheumatic arthralgia, muscle spasm, traumatic injury, carbuncle, swollen and sore. "Compendium of Materia Medica": eliminate carbuncle various poisons, protect the heart, promote blood circulation and relieve pain, treat women with dystocia and fractures. Frankincense frankincense channeling, can enter the heart meridian, activate blood circulation and relieve pain, so it is an essential medicine for carbuncle sores and confidant pain. ... obstetrics and various prescriptions are used for many purposes, and they are also used for their blood-activating effects. "Famous Doctors": "Treat Fengshui toxin and swollen, remove bad qi." "Treat wind-addicted prurigo." The chemical composition is: resin 60%-70%, gum 27%-35%, volatile oil 3%-8%. The main components of the resin are free a, β-boswellic acid (a, β-boswellic acid) 33%, combined boswellic acid 13.5%; mastic resin hydrocarbon (olibanoresene) 33%; gum is arabic acid (arabic acid) Calcium and magnesium salts of 20%, astragalus glue (bassorin) 6%. In addition, it still contains 0.5% bitterness and volatile oil. The main pharmacological effects are: (1) Analgesic effect: It was proved by mouse hot plate method that frankincense volatile oil has analgesic effect, and the residue after extracting volatile oil is invalid. The analgesic in volatile oil is mainly n-octyl acetate. (2) Anti-inflammatory and antiseptic effect: Frankincense can promote the increase of polynuclear leukocytes to phagocytose dead blood cells and cells, improve metabolism, and thus play an anti-inflammatory effect. Combined with myrrh, realgar, etc., it can reduce swelling and regenerate muscles, and it is a ministerial medicine.
没药(Commiphora myrrha Engl.),为橄榄科植物地丁树Commiphora myrrhaEngl.或哈地丁树Commiphora molmol Engl.的干燥树脂。味辛、苦,性平。具有散瘀定痛,消肿生肌之功效。常用于胸痹心痛,胃脘疼痛,痛经经闭,产后瘀阻,癥瘕腹痛,风湿痹痛,跌打损伤,痈肿疮疡等病症的治疗。化学成分为:α-罕没药酸和β-罕没药酸(Heerabomyrrholicacid)、α-没药酸、β-没药酸和γ-没药酸(Commiphoric acid)、没药次酸(Commiphorinicacid)、α-罕没药酚和β-罕没药酚(α-Heerabomyrrhol、β-Heerabomyrrhol)、罕没药树脂(Heeraboresene);另含挥发油,其成分为丁香油酚、间苯甲酚、枯醛、桂皮醛、罕没药烯(Heerabolene)等。药理作用为:(1)没药水浸剂对堇色毛癣菌等皮肤真菌有抑制作用;(2)没药的挥发油也能轻度抑制皮肤真菌;(3)没药还能降低兔、大鼠及鸡的血胆甾醇水平,并有抗炎作用。《本草纲目》:乳香活血,没药散血,皆能止痛消肿,生肌,故二药每每相兼而用。Myrrha (Commiphora myrrha Engl.) is the dry resin of Commiphora myrrha Engl. or Commiphora molmol Engl. of the olive family tree. Pungent, bitter, flat in nature. It has the effect of dispersing blood stasis and calming pain, reducing swelling and promoting muscle growth. Commonly used for the treatment of chest pain, epigastric pain, dysmenorrhea, amenorrhea, postpartum stasis, abdominal pain due to Zhengjia, rheumatic arthralgia, traumatic injury, carbuncle, swollen sore and other diseases. The chemical composition is: α-bisadol and β-heerabomyrrholic acid, α-bisabolic acid, β-bisabolic acid and γ-bisabolic acid, Commiphorinic acid , α-Hempabolol and β-Hempabolol (α-Heerabomyrrhol, β-Heerabomyrrhol), Heeraboresene; also contains volatile oil, the components of which are eugenol, m-phenol, citral , Cinnamaldehyde, Heerabolene, etc. The pharmacological effects are: (1) Myrrh water infusion has inhibitory effect on dermatophytes such as Trichophyton violaceum; (2) The volatile oil of myrrh can also slightly inhibit dermatophytes; (3) Myrrh can also reduce the incidence of Blood cholesterol levels in mice and chickens, and have anti-inflammatory effects. "Compendium of Materia Medica": frankincense activating blood, myrrh dispersing blood, all can relieve pain, reduce swelling, and build muscle, so the two medicines are used in each phase.
白芨(Bletilla striata(Thunb.)Reichb.F.)又名连及草、甘根、白给、箬兰、朱兰(《花镜》),紫兰、紫蕙、百笠。属多年生草本球根植物(块根)。止血良药,性味苦、甘涩、微寒、无毒。功能收敛止血,消肿生肌。主治内外伤出血。用于咳血吐血,外伤出血,疮疡肿毒,皮肤皲裂;肺结核咳血,溃疡病出血。块茎主要含联苄类化合物、二氧菲类化合物、联菲类化合物、双菲醚类化合物、二氢菲并吡喃类化合物、具螺内酯的菲类衍生物、菲类糖苷化合物、其他菲类化合物、苄类化合物、蒽类化合物、酸类成分、醛类成分;新鲜块茎另含白芨甘露聚糖(bletillamannan)。《神农本草经》:“主痈肿、恶疮、败疽,伤阴死肌,胃中邪气。”《本草纲目》:“气味(根)苦、平、无毒。”民族用药:【佤药】白芨,白极:球茎用于肺结核咳血,肠胃出血,烫伤,烧伤《中佤药》。【彝药】大白芨:块根治疗肺痨咯血,金创出血,烫伤灼伤,手脚皲裂《哀牢》。假鳞茎用于手脚骨折《滇省志》。阿图罗波:治疗肺结核,百日咳,支气管扩张,矽肺,胃及十二指肠溃疡急性穿孔,结核性痿管,烧伤及外科创伤,肛裂等《彝植药》。【仫佬药】大结巴:块茎治跌打内、外伤《桂药编》。【景颇药】Lahoiban:功用同德昂族《德宏药录》。铺赊做:根茎用于肺结核,支气管扩张咯血,胃溃疡吐血,尿血,便血,外伤出血,烧伤,阳痿《滇药录》。【土药】若克(rofkevyler):根茎治疗肺痨病,咳血,便血,皮肤皲裂,烧、烫伤《土家药》。Baiji (Bletilla striata (Thunb.) Reichb.F.) is also known as Lianhecao, Gangen, Baijie, Ruolan, Zhulan ("Flowering Mirror"), purple orchid, Zihui, and Baili. It is a perennial herbaceous bulbous plant (root tuber). A good medicine for hemostasis, bitter in nature, sweet and astringent, slightly cold, non-toxic. Function convergence and hemostasis, swelling and muscle regeneration. Indications of internal and external trauma bleeding. For hemoptysis and hematemesis, traumatic hemorrhage, sore swelling and toxin, chapped skin; pulmonary tuberculosis hemoptysis, ulcer bleeding. Tubers mainly contain bibenzyl compounds, dioxyphenanthrene compounds, biphenanthrene compounds, bisphenanthrene compounds, dihydrophenanthropyrans, phenanthrene derivatives with spironolactone, phenanthrene glycosides, and other phenanthrenes Compounds, benzyl compounds, anthracene compounds, acid components, aldehyde components; fresh tubers additionally contain bletillamannan. "Shen Nong's Materia Medica": "maintains carbuncle, malignant sore, gangrene, injures yin dead muscle, and evil qi in the stomach." "Compendium of Materia Medica": "The smell (root) is bitter, flat, and non-toxic." Ethnic medicine: 【WA Medicine] Baiji, Baiji: bulbs are used for tuberculosis hemoptysis, gastrointestinal bleeding, scalds, burns "Zhongwa Medicine". [Yi medicine] Dabaiji: tuberous root to treat pulmonary tuberculosis, hemoptysis, bleeding from gold wounds, scalds and burns, and cracked hands and feet. Pseudobulbs are used for fractures of hands and feet. Arturopo: Treatment of tuberculosis, whooping cough, bronchiectasis, silicosis, acute perforation of gastric and duodenal ulcers, tuberculous atrophy, burns and surgical trauma, anal fissures, etc. [Mulao Medicine] Big stammer: Tuber treats internal and traumatic injuries from "Gui Yao Bian". [Jingpo Medicine] Lahoiban: It is used in the "Dehong Medicine Record" of the same Deang people. Shop on credit: rhizomes are used for tuberculosis, bronchiectasis, hemoptysis, hematemesis in gastric ulcer, hematuria, blood in the stool, traumatic hemorrhage, burns, impotence. [Local Medicine] Ruoke (rofkevyler): rhizomes treat pulmonary tuberculosis, hemoptysis, blood in the stool, chapped skin, burns, and scalds "Tujia Medicine".
蜂蜡,又称黄蜡、蜜蜡。蜂蜡是由蜂群内适龄工蜂腹部的4对蜡腺分泌出来的一种脂肪性物质。性味甘,微温。具有收涩,敛疮,生肌,止痛,调理。外用于溃疡不敛,臁疮糜烂,创伤,烧、烫伤。常作成药赋型剂及油膏基质。其主要成分可分为4大类,即酯类、游离酸类、游离醇类和烃类;此外还含微量的挥发油及色素;据称尚含一种芳香性有色物质,名为虫蜡素(Cerolein)。药理作用:(1)活性氨清除作用;(2)其他作用,蜂蜡及其乳浊液有抑菌和防腐作用。《本草通玄》:贴疮生肌止痛。《本经》:主下痢脓血,补中,续绝伤,金疮,益气。在《医林集要》、《王仲勉经验方》、《千金翼方》中均有治汤火伤疮等记载。Beeswax, also known as yellow wax, beeswax. Beeswax is a fatty substance secreted by 4 pairs of wax glands in the abdomen of worker bees of appropriate age in the colony. Sweet, lukewarm. Has astringent, astringent sores, muscle regeneration, pain relief, conditioning. Externally used for ulcers that do not converge, ecthyma erosion, wounds, burns and scalds. Often made into pharmaceutical excipients and ointment base. Its main components can be divided into 4 categories, namely esters, free acids, free alcohols and hydrocarbons; in addition, it also contains trace amounts of volatile oils and pigments; it is said that it still contains an aromatic colored substance called insect wax. (Cerolein). Pharmacological effects: (1) Active ammonia scavenging effect; (2) Other effects, beeswax and its emulsion have bacteriostatic and antiseptic effects. "Materia Medica Tongxuan": paste the sore muscle and relieve pain. "Benjing": the main pus and blood in diarrhea, invigorating the middle, continuing the injury, golden sore, benefiting qi. In "Medical Forest Collection", "Wang Zhongmian's Experience Prescriptions", and "Qianjin Yifang", there are records of treating decoction for burns and sores.
冰片,又名龙脑(《别录》),脑子(《海上方》),龙脑(《本草图经》),梅花脑子(《小儿药证直诀》),梅花片脑(《夷坚志》),片脑(《寿域神方》),梅花脑、冰片脑(《纲目》),梅片、梅冰。是由菊科艾纳香茎叶或樟科植物龙脑樟枝叶经水蒸汽蒸馏并重结晶而得。气清香,性辛、苦,微寒。具有清香宣散,具有开窍醒神,清热散毒,明目退翳的功效,主治热病高热神昏,中风痰厥惊痫,暑湿蒙蔽清窍,喉痹耳聋,口疮齿肿,疮痈疳痔,目赤肿痛,翳膜遮睛。在辽宁《中草药新医疗法资料选编》记载冰片治烫、烧伤。《医林纂要》:“冰片主散郁火,能透骨热,治惊痫、痰迷、喉痹,舌胀、牙痛、耳聋、鼻息、目赤浮翳、痘毒内陷、杀虫、痔疮、催生,性走而不守,亦能生肌止痛。然散而易竭,是终归阴寒也。”临床应用:(1)治疗小儿烧伤:共治疗216例,其中46例通过较系统观察,结果浅Ⅱ度烧伤平均治愈天数约10天,深Ⅱ度烧伤平均治愈天数约24天。(2)治疗溃疡性口腔炎。(3)治疗慢性鼻腔炎。(4)治疗化脓性中耳炎。(5)治疗蛲虫病。(6)治疗慢性气管炎等。Borneol, also known as borneol ("Bie Lu"), brain ("Over the Sea"), borneol ("Bencao Jing"), Plum Blossom Brain ("Children's Medicine Syndrome Zhi Jue"), Plum Blossom Pian Nao ("Yijian") Zhi"), Pian Nao ("Shou Yu Shen Fang"), Plum Blossom Nao, Born Pian Nao ("Outline"), Plum Pian, Mei Bing. It is obtained by steam distillation and recrystallization from the stems and leaves of Aina incense, or the branches and leaves of Lauraceae. The air is fragrant, pungent, bitter, slightly cold in nature. It has the functions of clearing the orifices and refreshing the mind, clearing heat and dispelling toxins, improving eyesight and relieving nebula. It is mainly used to treat febrile diseases, high fever, dizziness, stroke, phlegm convulsions, epilepsy, heat-dampness, blindness and clear orifices, throat obstruction, deafness, aphthous and swollen teeth, sores and carbuncles. chancre hemorrhoids, red eyes, swelling and pain, nebula covering the eyes. In Liaoning's "Selected Materials of the New Medical Law of Chinese Herbal Medicine", it is recorded that borneol is used to treat scald and burns. "Medical Forest Compilation": "Borneol mainly disperses stagnation fire, can penetrate bone heat, treat epilepsy, phlegm, throat paralysis, tongue swelling, toothache, deafness, snoring, red eyes and nebula, pox invagination, and insecticide. , hemorrhoids, procreation, and non-observation of sex, it can also generate muscle and relieve pain. However, it is easy to be exhausted, and it is ultimately cold." Clinical application: (1) Treatment of pediatric burns: A total of 216 cases were treated, of which 46 cases passed the systematic comparison Observation showed that the average healing days for superficial second-degree burns were about 10 days, and the average healing days for deep second-degree burns were about 24 days. (2) Treatment of ulcerative stomatitis. (3) Treatment of chronic rhinitis. (4) Treatment of suppurative otitis media. (5) Treatment of enterobiasis. (6) Treatment of chronic bronchitis, etc.
所述米蒿制剂剂型为糊剂。The dosage form of the Artemisia annua preparation is a paste.
一种用于烧烫伤的米蒿复方制剂的制备方法,包含以下具体步骤:A preparation method for the compound preparation of Artemisia annua for burns and scald, comprising the following concrete steps:
(1)称取配方量的米蒿种子在预热的容器内焙烤,快速翻炒至有爆破声,将焙烤好的米蒿种子放凉,粉碎,备用;(1) take by weighing the wormwood seeds of the formula and bake in a preheated container, stir-fry quickly until there is a popping sound, cool the roasted wormwood seeds, pulverize, and set aside for subsequent use;
(2)称取配方量的血竭、大黄炒炭后,粉碎,过筛,备用;(2) after taking by weighing the dried blood, rhubarb and charcoal of the formula amount, pulverize, sieve, for subsequent use;
(3)称取配方量的乳香、没药粉碎后,过筛,备用;(3) after taking by weighing the frankincense and myrrh of the formula quantity and pulverizing, sieve for subsequent use;
(4)称取配方量的白屈菜,采用80%乙醇提取,滤液浓缩至浸膏状,备用;(4) take by weighing the celandine of formula amount, adopt 80% ethanol extraction, and the filtrate is concentrated to extract, for subsequent use;
(5)称取配方量的紫草、白芨粉碎后,加入适量亚麻籽油中加热,趁热过滤,取滤油,备用;(5) after taking by weighing the comfrey and Bletilla striata of the formula amount and pulverizing, add an appropriate amount of linseed oil and heat, filter while hot, and get the filter oil for subsequent use;
(6)称取配方量的地榆在预热的容器内焙烤,焙烤至焦黄色,将焙烤好的地榆放凉,粉碎,过筛,备用;(6) take by weighing the Burnet of the formula amount and bake in the preheated container, bake until the charred yellow, let the roasted Burnet cool, pulverize, sieve, for subsequent use;
(7)取步骤(6)中的地榆粉、配方量的蜂蜡加入步骤(5)中煮沸的滤油中搅拌,降温,加入步骤(2)中的血竭粉以及配方量的冰片,搅拌至冰片溶解,放至室温备用;(7) get the Burnet powder in step (6), the beeswax of formula amount and add in the filtered oil boiled in step (5) and stir, cooling, add the dried blood powder in step (2) and the borneol of formula amount, stir Until the borneol dissolves, put it at room temperature for later use;
(8)取步骤(3)中的乳香粉以及没药粉,加入适量亚麻籽油中拌和,将其与步骤(2)中的大黄粉加入步骤(7)中的备用料中,搅拌均匀,备用;(8) Take the frankincense powder and myrrh powder in step (3), add an appropriate amount of linseed oil and mix, add it and the rhubarb powder in step (2) to the standby material in step (7), stir evenly, and set aside for later use ;
(9)将步骤(1)中的米蒿粉加入到剩余的亚麻籽油中,拌和,得米蒿糊备用;(9) the Artemisia annua powder in step (1) is joined in the remaining linseed oil, mixes, obtains Artemisia annua paste for subsequent use;
(10)将步骤(4)中的白屈菜浸膏和步骤(9)中制备的米蒿糊加入到步骤(8)的备用料中,搅拌均匀,即得红棕色糊状制剂。(10) Add the celandine extract in step (4) and the rice wormwood paste prepared in step (9) to the standby materials in step (8), and stir evenly to obtain a reddish-brown paste preparation.
步骤(1)中预热温度为100℃,焙烤3-5秒。In step (1), the preheating temperature is 100° C., and the baking is performed for 3-5 seconds.
步骤(3)中乳香、没药置于120℃烘烤2h,冷却至室温,再粉碎。In step (3), frankincense and myrrh were baked at 120° C. for 2 hours, cooled to room temperature, and then pulverized.
步骤(2)、(3)以及(6)中粉末均过100目筛。The powders in steps (2), (3) and (6) are all passed through a 100-mesh sieve.
步骤(4)中白屈菜用80%乙醇回流提取两次,第一次提取2h,第二次提取1.5h,分别过滤,合并滤液。In step (4), celandine was extracted twice by refluxing with 80% ethanol, the first extraction was 2 hours, the second extraction was 1.5 hours, filtered respectively, and the filtrates were combined.
步骤(5)中将亚麻籽油加热至115℃,加热时间为30min。In step (5), the linseed oil is heated to 115° C., and the heating time is 30 min.
步骤(7)中降温至56℃,再加入步骤(2)中的血竭粉以及配方量的冰片。In step (7), the temperature is lowered to 56° C., and then the dried blood powder in step (2) and the borneol in the formula amount are added.
本发明所达到的有益效果:本发明中,首次将米蒿种子用于治疗烧烫伤的中药制剂中,将其与其他中药或中药提取物组合使用,可以促进治疗效果,将其制成糊剂,具有均匀性、延展性、吸附性、成纤性和吸湿性好以及粘度适中的特点。Beneficial effects achieved by the present invention: In the present invention, Artemisia annua seeds are used for the first time in a traditional Chinese medicine preparation for treating burns and scalds, and they are used in combination with other traditional Chinese medicines or traditional Chinese medicine extracts to promote the therapeutic effect, and are made into pastes , has the characteristics of uniformity, ductility, adsorption, fiber-forming and hygroscopicity, and moderate viscosity.
附图说明Description of drawings
图1是实施例中对照组、米蒿单方油剂以及米蒿复方糊剂给小鼠用药后治疗效果对比图;Fig. 1 is a comparison chart of the therapeutic effect after control group, Artemisia annua unilateral oil preparation and Artemisia annua compound paste are administered to mice in the embodiment;
图2是实施例中小鼠正常皮肤、对照组、米蒿单方油剂以及米蒿复方糊剂给小鼠用药后皮肤病理切片对比图。Figure 2 is a comparison diagram of skin pathological sections after the normal skin of mice, the control group, the single oil preparation of Artemisia annua and the compound paste of Artemisia annua are administered to the mice in the embodiment.
具体实施方式Detailed ways
下面结合附图对本发明作进一步描述。以下实施例仅用于更加清楚地说明本发明的技术方案,而不能以此来限制本发明的保护范围。The present invention will be further described below in conjunction with the accompanying drawings. The following examples are only used to illustrate the technical solutions of the present invention more clearly, and cannot be used to limit the protection scope of the present invention.
1、一种用于烧烫伤的米蒿单方油剂1. A kind of rice wormwood single oil preparation for burns and scalds
主要原料为:米蒿种子20g,亚麻籽油30ml。The main raw materials are: Artemisia annua seeds 20g, linseed oil 30ml.
制备方法:(1)取米蒿种子20g,放于预先加热至100℃的瓦片上焙烤3-5秒,同时迅速翻炒至有爆破声;Preparation method: (1) Take 20 g of Artemisia annua seeds, put them on a tile preheated to 100°C and bake for 3-5 seconds, and at the same time stir-fry quickly until there is a popping sound;
(2)将焙烤好的米蒿种子迅速转入白瓷盘中放凉,于研钵中研磨成粉末状;(2) the roasted Artemisia seeds is quickly transferred into the white porcelain plate and allowed to cool, and is ground into powder in a mortar;
(3)取30ml亚麻籽油,加入研磨好的米蒿粉中,拌合成浅棕黄色油状膏体,备用。(3) Take 30ml of linseed oil, add it to the ground rice wormwood powder, mix it into a light brown-yellow oily paste, and set aside.
2、一种用于烧烫伤的米蒿复方糊剂2. A rice wormwood compound paste for burns and scalds
主要原料为:米蒿种子25g,地榆5g,血竭2.5g,大黄5g,乳香1g,没药1g,白屈菜10g,紫草25g,白芨5g,蜂蜡5g,冰片2.5g,亚麻籽油约90ml。The main raw materials are: Artemisia annua seeds 25g, Burnet 5g, Draconis 2.5g, Rhubarb 5g, Frankincense 1g, Myrrh 1g, Celandine 10g, Comfrey 25g, Bletilla striata 5g, Beeswax 5g, Borneol 2.5g, Flaxseed oil About 90ml.
制备方法:(1)将米蒿种子置于预先加热至100℃的瓦片上焙烤3-5秒,同时迅速翻炒至有爆破声;Preparation method: (1) Place the seeds of Artemisia annua on a tile preheated to 100° C. and bake for 3-5 seconds, and at the same time quickly stir-fry until there is a popping sound;
(2)将焙烤好的米蒿种子迅速倒入白瓷盘中放凉,于研钵中研磨成粉末状,备用;(2) the roasted Artemisia seeds are quickly poured into a white porcelain plate and allowed to cool, and ground into powder in a mortar, for subsequent use;
(3)血竭,大黄炒碳,研磨成粉状;分别过100目筛,备用;(3) dried blood, rhubarb stir-fried with carbon, ground into powder; pass through a 100-mesh sieve respectively, for use;
(4)将乳香、没药置于120℃烘烤2h,冷却至室温,研磨成粉状,过100目筛,备用;(4) Bake frankincense and myrrh at 120°C for 2 hours, cool to room temperature, grind into powder, pass through a 100-mesh sieve, and set aside for later use;
(5)取白屈菜10g,分别用80%乙醇加热回流提取2h,过滤得滤液;滤渣再用80%乙醇加热回流提取1.5h,过滤,合并滤液,浓缩至浸膏状;(5) Take 10 g of celandine, extract with 80% ethanol under reflux for 2 hours, and filter to obtain a filtrate; filter residues with 80% ethanol under reflux for extraction for 1.5 hours, filter, combine the filtrates, and concentrate to extract;
(6)分别取粉碎后的紫草25g,白芨5g,加入50ml亚麻籽油,在115℃加热30min,趁热过滤得滤油,备用;(6) respectively take 25g of pulverized comfrey, 5g of Bletilla striata, add 50ml linseed oil, heat at 115 DEG C for 30min, filter while hot to obtain filter oil, for subsequent use;
(7)地榆焙干、磨粉,过100目筛;取地榆粉5g、蜂蜡5g加入煮沸的滤油(6)中,搅拌,放置到56℃,分别加入血竭粉2.5g,冰片2.5g,搅拌至冰片溶解;放置室温备用;(7) Burnet is dried, ground, and passed through a 100-mesh sieve; 5 g of Burnet powder and 5 g of beeswax are added to the boiled oil filter (6), stirred, placed at 56°C, and 2.5 g of dried blood powder, borneol are added respectively. 2.5g, stir until the borneol dissolves; leave at room temperature for later use;
(8)分别取乳香粉1g、没药粉1g,加入到10ml亚麻籽油中拌合均匀;再与大黄粉5g、加入到(7)中,搅拌均匀,备用;(8) respectively get frankincense powder 1g, myrrh powder 1g, join in 10ml linseed oil and mix well; add 5g of rhubarb powder to (7) again, stir well, standby;
(9)将米蒿粉25g加热到30ml亚麻籽油中,拌合均匀,得米蒿糊备用;(9) Heat 25g of Artemisia argyi powder into 30ml of linseed oil, mix well, and obtain Artemisia argyi paste for subsequent use;
(10)将(5)制备的白屈菜浓缩液和(9)制备的米蒿糊,加入到(8)中,搅拌混匀后,得到红棕色的糊状制剂。(10) The celandine concentrate prepared in (5) and the rice wormwood paste prepared in (9) were added to (8), and after stirring and mixing, a reddish-brown paste preparation was obtained.
3、烧烫伤造模实验3. Burn and scald modeling experiment
3.1、实验对象3.1. Experimental subjects
BALB/c小鼠。雌雄各半,平均体重18-22g,清洁级饲养。BALB/c mice. Half male and half female, with an average weight of 18-22g, and kept at clean level.
3.2、实验材料3.2. Experimental materials
LKTC-L,CONTROLLE恒温水浴锅(金坛区西城新瑞仪器厂),手术镊,剪刀,10g砝码(湘仪天平仪器厂),计时器,细绳,脱毛器。LKTC-L, CONTROLLE constant temperature water bath (Jintan District Xicheng Xinrui Instrument Factory), surgical tweezers, scissors, 10g weight (Xiangyi Balance Instrument Factory), timer, string, epilator.
3.3、模型制备3.3. Model preparation
恒温水浴锅加热至100℃并恒温,将拴好细绳的10g砝码,放置于水浴锅中预热约10min,小鼠背部用脱毛器脱毛,乙醚麻醉后,用预热的砝码进行背部热烫5s,同一部位连续热烫两次,在小鼠背部烫出直径1cm的圆形烫伤区,即为Ⅱ级烫伤。The constant temperature water bath was heated to 100°C and kept at a constant temperature. The 10g weight tied with the string was placed in the water bath and preheated for about 10 minutes. The back of the mouse was depilated with an epilator. After ether anesthesia, the back was treated with the preheated weight After scalding for 5 s, the same part was scalded twice in a row, and a circular scalded area with a diameter of 1 cm was scalded on the back of the mouse, which was a grade II scald.
3.4、模型给药3.4. Model drug delivery
将小鼠随机分成3组,即对照组、米蒿单方油剂组和米蒿复方糊剂组,于早中晚分别用棉棒在烫伤部位涂药,每天用药三次。对照组小鼠背部皮肤每天涂抹辅料亚麻籽油,同用药组操作。用药7天后处死小鼠,分别取其损伤皮肤组织及周围正常皮肤组织,在4%多聚甲醛中固定2天,石蜡包埋,HE染色,进行组织学的观察。Mice were randomly divided into 3 groups, namely the control group, the single oil preparation group of Artemisia annua and the compound paste group of Artemisia annua. Cotton swabs were used to apply medicine to the scalded area in the morning, noon and evening, three times a day. The back skin of mice in the control group was smeared with linseed oil as an adjunct every day, and the same operation was performed as in the medication group. Mice were sacrificed 7 days after administration, and the damaged skin tissue and surrounding normal skin tissue were collected, fixed in 4% paraformaldehyde for 2 days, embedded in paraffin, and stained with HE for histological observation.
4、治疗效果4. Therapeutic effect
如图1所示,为对照组、米蒿单方油剂以及米蒿复方糊剂给小鼠用药后治疗效果对比,观察发现:对照组小鼠烫伤的皮肤创伤部分发生烫伤性溃烂,组织严重肿胀,细胞形态模糊变异,同时出现部分坏死,颜色呈白色与红肿,与周周正常组织形成鲜明的对比;用药组小鼠用药后,创面结一层不同程度的红紫色干痂;其中米蒿复方糊剂用药效果明显好于米蒿单方油剂,用复方糊剂治疗后第2天烫伤皮肤开始结痂;用药4天后,形成一层较厚的深紫红色干痂,同时组织肿胀明显减轻;用药6天后,深紫红色干痂变得干燥,烫伤部位边缘结痂翘起;用药7天后,周围有肉芽组织向内生长,组织上面仍有一层厚厚的干燥的结痂,创伤面积明显缩小。As shown in Figure 1, it is a comparison of the therapeutic effects of the control group, the single oil preparation of Artemisia annua L. and the compound paste of Artemisia annua L. , the cell morphology was blurred and mutated, and partial necrosis appeared at the same time, and the color was white and red and swollen, which formed a sharp contrast with the normal tissue in the surrounding area. The effect of the paste is obviously better than that of the Artemisia annua single oil. The scalded skin begins to form scabs on the 2nd day after treatment with the compound paste; after 4 days of application, a thick layer of dark purple-red dry scabs is formed, and the tissue swelling is significantly reduced at the same time; After 6 days of medication, the dark purple-red dry scab became dry, and the scab on the edge of the scalded area lifted up; after 7 days of medication, there was ingrowth of granulation tissue around, and there was still a thick layer of dry scab on the tissue, and the wound area was significantly reduced .
如图2所示,为小鼠正常皮肤,对照组、米蒿单方油剂以及米蒿复方糊剂给小鼠用药后皮肤病理切片,组织形态学镜下观察,与正常小鼠皮肤组织比较,对照组小鼠烫伤皮肤结构发生凝固性坏死,其中表皮及真皮结构损伤严重;部分组织脱落,烫伤深度达到真皮深层,呈深Ⅱ度烫伤特点;用药组小鼠用药7天后,烫伤皮肤组织层次结构恢复,米蒿复方糊剂治疗后皮肤结构恢复得明显好于米蒿单方油剂组,皮肤组织结构清晰,产生出肥大细胞、巨噬细胞聚集,同时伴有成纤维细胞、胶原物质生成,深层结构汗腺、毛囊腺基本恢复,表皮层次结构日趋完整,皮肤处于恢复状态中,表皮几乎完整。As shown in Figure 2, for the normal skin of mice, the control group, the single oil preparation of Artemisia annua and the compound paste of Artemisia annua were administered to the mice with skin pathological sections, observed under histomorphological microscope, and compared with the normal mouse skin tissue, The scalded skin structure of the mice in the control group had coagulation necrosis, and the epidermis and dermis were severely damaged; some tissues fell off, and the scalded depth reached the deep dermis, showing the characteristics of deep second-degree scald; the mice in the treatment group were treated for 7 days, and the scalded skin tissue hierarchy Recovery, the recovery of skin structure after treatment with Mihao compound paste was significantly better than that in Mihao single oil group. The structure of sweat glands and hair follicle glands is basically restored, the epidermis hierarchy is becoming more and more complete, the skin is in a state of recovery, and the epidermis is almost complete.
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明技术原理的前提下,还可以做出若干改进和变形,这些改进和变形也应视为本发明的保护范围。The above are only the preferred embodiments of the present invention. It should be pointed out that for those skilled in the art, without departing from the technical principle of the present invention, several improvements and modifications can also be made. These improvements and modifications It should also be regarded as the protection scope of the present invention.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810189215.0A CN108186900B (en) | 2018-03-08 | 2018-03-08 | A kind of Artemisia annua compound preparation for burn and scald and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810189215.0A CN108186900B (en) | 2018-03-08 | 2018-03-08 | A kind of Artemisia annua compound preparation for burn and scald and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108186900A CN108186900A (en) | 2018-06-22 |
CN108186900B true CN108186900B (en) | 2020-12-01 |
Family
ID=62595192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810189215.0A Active CN108186900B (en) | 2018-03-08 | 2018-03-08 | A kind of Artemisia annua compound preparation for burn and scald and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108186900B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3943248A (en) * | 1974-11-04 | 1976-03-09 | Shulman Max J | Methods of treating burns using colophony containing preparations |
CN1075877A (en) * | 1992-05-10 | 1993-09-08 | 株洲市财贸职工医院 | A kind of preparation method of burn ointment |
CN1432378A (en) * | 2002-01-17 | 2003-07-30 | 傅元庆 | Medicine for treating burns and scalds and its prepn process |
CN1772145A (en) * | 2005-11-01 | 2006-05-17 | 黄绍恒 | Medicine ointment for treating burns and scalds and its prepn |
CN101716209A (en) * | 2009-12-02 | 2010-06-02 | 中国科学院西北高原生物研究所 | Artemisia dalai-lamae Krasch. essential oil and preparation method and application thereof |
-
2018
- 2018-03-08 CN CN201810189215.0A patent/CN108186900B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3943248A (en) * | 1974-11-04 | 1976-03-09 | Shulman Max J | Methods of treating burns using colophony containing preparations |
CN1075877A (en) * | 1992-05-10 | 1993-09-08 | 株洲市财贸职工医院 | A kind of preparation method of burn ointment |
CN1432378A (en) * | 2002-01-17 | 2003-07-30 | 傅元庆 | Medicine for treating burns and scalds and its prepn process |
CN1772145A (en) * | 2005-11-01 | 2006-05-17 | 黄绍恒 | Medicine ointment for treating burns and scalds and its prepn |
CN101716209A (en) * | 2009-12-02 | 2010-06-02 | 中国科学院西北高原生物研究所 | Artemisia dalai-lamae Krasch. essential oil and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN108186900A (en) | 2018-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102091203B (en) | External traditional Chinese medicine preparation for treating refractory wound and preparation method thereof | |
CN103393953B (en) | Traditional Chinese medicine ointment for promoting postoperative wound healing, and preparation method thereof | |
CN102205026B (en) | Chinese medicinal composition for treating children chronic sinusitis and preparation method thereof | |
CN108888676A (en) | A kind of Chinese medicine composition and preparation method thereof for treating eczema | |
CN106620539A (en) | External ointment for treating skin diseases as well as preparation method and application thereof | |
CN104288504B (en) | A kind of Chinese medicine ointment formulation for treating burn, scald and preparation method thereof | |
CN106668274A (en) | Externally-used traditional Chinese medicine health care preparation with beauty treatment, pain relief and itching relief and preparation method thereof | |
CN101837082A (en) | Chinese preparation for treating burn without leaving scar | |
CN108186901B (en) | A kind of Artemisia annua compound preparation for burn and scald and preparation method thereof | |
CN115120690B (en) | Traditional Chinese medicine composition for treating precocious puberty and application thereof | |
CN1088449A (en) | Cancer pain curing medicine and preparation method thereof | |
CN102764345B (en) | Basil-bluegum ointment for curing burns and preparation method thereof | |
CN110652552A (en) | Wound healing formula and preparation method | |
CN108186900B (en) | A kind of Artemisia annua compound preparation for burn and scald and preparation method thereof | |
CN102688368B (en) | Traditional Chinese medicine for treating trauma hemostasis or telephium | |
CN108159103B (en) | A kind of Artemisia annua preparation for burn and scald and preparation method thereof | |
CN104623304A (en) | Lotion for treating chronic skin ulcer caused by damp-heat and toxicity accumulation and preparation method of lotion | |
CN105327244A (en) | Traditional Chinese medicine composition containing folium artemisiae argyi and used for treating bedsores and preparing method thereof | |
CN111265566A (en) | A Chinese medicinal composition for treating fracture, and its preparation method | |
CN104491371A (en) | Swelling and lump removing plaster for chronic breast tuberculosis and preparation method | |
CN110123976A (en) | It is a kind of to treat hemorrhoid dai medicine smearing cream and preparation method thereof | |
CN108815268A (en) | A kind of external application promotees the Chinese medicine ointment formulation and preparation method thereof of union of wounded skin | |
CN105853843A (en) | Pharmaceutical composition for clinical pediatric wound care and preparation method of pharmaceutical composition for clinical pediatric wound care | |
CN115887601A (en) | Composition for treating hemorrhoids and preparation method thereof | |
CN117982592A (en) | Traditional Chinese medicine composition for treating skin injury scar and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200812 Address after: No. 18877, Jingshi Road, Jinan, Shandong Province Applicant after: Shandong First Medical University (Shandong Academy of Medical Sciences) Address before: 271000 No. 619, the Great Wall Road, Tai'an, Shandong Applicant before: TAISHAN MEDICAL University |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |